68Ga-DOTA-Tyr3-Octreotide PET for Assessing Response to Somatostatin-Receptor–Mediated Radionuclide Therapy
Tóm tắt
Từ khóa
Tài liệu tham khảo
Gabriel M, Andergassen U, Putzer D, et al. Innsbruck experience with targeted radionuclide therapy using different radiolabeled somatostatin analogs [abstract]. Eur J Nucl Med Mol Imaging . 2007;34(suppl 2):S220.
Oberg K, Jelic S; ESMO Guidelines Working Group. Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol . 2008;19(suppl 2):ii104–ii105.
2005, J Nucl Med., 46, 76S
2006, Anticancer Res., 26, 703
2004, Eur J Nucl Med Mol Imaging., 31, 1038
2005, J Nucl Med., 46, 1310
2002, J Nucl Med., 43, 610
1999, J Nucl Med., 40, 1602